NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Mayor Eric Johnson outlined Dallas’ business growth, public safety trends, and economic priorities during an MCBA luncheon.Read More
